BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 72.60
+0.70 (0.97%)
May 8, 2026, 1:30 PM CST
BIONET Market Cap
BIONET has a market cap or net worth of 3.65 billion as of May 8, 2026. Its market cap has increased by 4.59% in one year.
Market Cap
3.65B
Enterprise Value
3.35B
Revenue
1.24B
Ranking
n/a
PE Ratio
71.18
Stock Price
72.60
Market Cap Chart
Since November 3, 2008, BIONET's market cap has increased from 1.14B to 3.65B, an increase of 219.37%. That is a compound annual growth rate of 6.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.65B | -29.86% |
| Dec 31, 2025 | 5.21B | 29.12% |
| Dec 31, 2024 | 4.03B | 47.30% |
| Dec 29, 2023 | 2.74B | 32.70% |
| Dec 30, 2022 | 2.06B | 9.73% |
| Dec 30, 2021 | 1.88B | -2.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DIVA Laboratories | 1.76B |
| Genetics Generation Advancement | 1.17B |
| Puriblood Medical | 920.68M |
| TFBS Bioscience | 824.56M |
| Kim Forest Enterprise | 788.11M |
| Sofiva Genomics | 703.94M |
| Pharmigene | 491.53M |
| Welgene Biotech | 414.82M |